MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze SHALBY.NS →
    • FindStock Picks / Stock Screener
    • Value · SHALBY.NSIntrinsic Value Calculator
    • Invest · SHALBY.NSInvestment Case
    • Hold · SHALBY.NS5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
SHAL

SHALBY.NS

Shalby Limited

$122.7
-0.36
 (-0.29%)
Exchange:  NSE
Market Cap:  13.193B
Shares Outstanding:  115.752M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – Care FacilitiesView industry performance
   
CEO:  Vikram Indrajit Shah
Full Time Employees:  2217
Address: 
B-301 & 302, Mondeal Heights
Ahmedabad
GJ
380015
IN
Website:  https://www.shalby.org
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
SHSHALBY.NS logoSHALBY.NSShalby Limited13.2B34.16,4440.0%
EHEHC logoEHCEncompass Health Corporation13.8B21.022.413.7%
FMFMS logoFMSFresenius Medical Care AG & Co. KGaA12.3B12.210.06.2%
DVDVA logoDVADaVita Inc.11.9B14.412.910.7%
ENENSG logoENSGThe Ensign Group, Inc.11.0B26.323.77.4%
UHUHS logoUHSUniversal Health Services, Inc.10.1B7.38.710.4%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202420252026
Revenue9,337,49010,869,55011,414,290
Gross Profit2,504,9502,016,4302,089,440
EBITDA1,895,3901,602,0201,434,380
Operating Income2,239,350668,460734,510
Net Income840,77062,220373,890

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202420252026
Total Assets16,075,32017,036,53018,391,300
Total Liabilities5,997,4507,083,2708,334,360
Total Stockholders Equity10,003,7409,921,88010,052,340
Total Debt3,778,6604,759,2705,945,850
Cash and Cash Equivalents271,810348,620219,370

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202420252026
Operating Cash Flow195,960-313,010-333,590
Capital Expenditure-471,070-714,460-1,490,450
Free Cash Flow-275,110-1,027,470-1,824,040
Net Income840,77062,220373,890
Net Change in Cash149,36076,570-129,050

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)11,860,950.078Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)11,860,950.078Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)11,860,950.078Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)3,743,112.201Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)3,743,112.201Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)3,743,112.201Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)1,990,934.417Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)1,990,934.417Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,990,934.417Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)769,805.647Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)769,805.647Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)769,805.647Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)17.200Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)17.200Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)17.200Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
1.1
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
34.08
?Enterprise Value
 (TTM)
: 
12.971B  ?EV/FCF
 (TTM)
: 
-19.32
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
3.92%  ?ROIC
 (TTM)
: 
0%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0
?P/B
 (TTM)
: 
1.33  ?Current Ratio
 (TTM)
: 
0

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
6,443.58Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates SHALBY.NS intrinsic value between $1.82 – $2.52 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate NS Intrinsic Value

Common questions about SHALBY.NS valuation

Is Shalby Limited (SHALBY.NS) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Shalby Limited (SHALBY.NS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SHALBY.NS a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SHALBY.NS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is SHALBY.NS’s P/E ratio?

You can see SHALBY.NS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for SHALBY.NS?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is SHALBY.NS a good long-term investment?

Whether SHALBY.NS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Shalby Limited

  • Shalby Limited intrinsic value calculatorEstimate what the business is worth
  • Shalby Limited 5-year outlookWhat has to go right, and what could go wrong
SHALBY.NS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.29
MarketSnap

Trading Metrics:

Open: 122.06   Previous Close: 123.06
Day Low: 119.41   Day High: 126.96
Year Low: 110.61   Year High: 244
Price Avg 50: 136.78   Price Avg 200: 154.69
Volume: 156222   Average Volume: 83608

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze SHALBY.NS →
    • FindStock Picks / Stock Screener
    • Value · SHALBY.NSIntrinsic Value Calculator
    • Invest · SHALBY.NSInvestment Case
    • Hold · SHALBY.NS5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read